EyePoint Statistics
NASDAQ: EYPTIndustrialsBiotechnology: Laboratory Analytical InstrumentsUSD
0.2342-0.03 (-11.36%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
EyePoint by the numbers
EyePoint has a market capitalization of $26.6 million based on 113.78M shares outstanding. With trailing EPS of $-3.97, EyePoint is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 87.8% below its 50-day average and 97.6% below its 200-day average.
Average daily trading volume is 8.37M shares, or about $2.0 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
EYPT valuation vs. peer median
| Metric | EYPT | Peer median | Difference |
|---|---|---|---|
| Market cap | $26.65M | $34.24M | -22% |
| Avg. volume | 8.37M | 396.66K | +2011% |
Peer median across 8 companies: PRPO, CIRC, RPID, HBIO, BNGO, ASTC, SEER, QTRX.
Valuation
- Market cap
- $26.65M
- Price / sales (latest FY)
- 0.85
- EPS (TTM)
- $-3.97
- Shares outstanding
- 113.78M
Price and trading
- Previous close
- 0.2642
- Open
- 0.26
- Day range
- 0.2277 – 0.265
- 52-week range
- 0.2277 – 19.11
- 52-week change
- -98.29%
- Beta
- —
- Volume
- 4.93M
- Average volume
- 8.37M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 12, 2026
Additional statistics
- Market Cap
- 26.65M
- Forward Pe
- -0.14
- Eps
- -3.97
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 19.11
- Week52 Low
- 0.23
- Avg Volume
- 8.37M
- Shares Outstanding
- 113.78M
- Ma50
- 1.92
- Ma200
- 9.91
- Earnings Date
- Nov 12, 2026
- Pct From52w High
- -98.77%
- Pct From52w Low
- 2.85%